–(BUSINESS WIRE)– Age Wave:
|
|
|
|
|
|
|
WHAT:
|
|
|
|
|
A multi-disciplinary team has been formed to work towards creating an XPRIZE for Alzheimer’s disease, currently afflicting more than 5.5 million people in the U.S. and costing $259 billion — numbers that are expected to grow exponentially as the U.S. population ages. Worldwide, almost 50 million are estimated to suffer from the disease. |
|
|
|
|
|
|
|
WHEN:
|
|
|
|
|
Thursday, September 7, 11am-12pm Eastern Time |
|
|
|
|
|
|
|
WHO:
|
|
|
|
|
George Vradenburg, JD, co-founder and chairman, UsAgainstAlzheimer’s
|
|
|
|
|
|
Ken Dychtwald, PhD, founder and CEO, Age Wave |
|
|
|
|
|
Lisa Genova, PhD, neuroscientist, author of best-selling Still Alice |
|
|
|
|
|
Philip Edgcumbe, PhD, global impact team leader |
|
|
|
|
|
|
|
HOW TO
ACCESS:
|
|
|
|
|
Dial-in #: 800-550-1215 (International callers: +1 213-233-3011)
|
|
|
|
|
Please RSVP to Robyn Reynolds at rreynolds@agewave.com.
|
|
|
|
|
There will be a Q&A session at the end of the call. Please submit any questions to questions@agewave.com.
|
|
|
|
|
|
|
|
THE BASIC
FACTS:
|
|
|
|
|
The initiative is to create the next XPRIZE for Alzheimer’s, specifically identifying a biotarget than can predict and prevent the disease. |
|
|
|
|
|
|
|
|
|
Existing approaches track the disease far too late. A predictive, non-invasive bio-target would unleash a new era of interventions and targeted treatments that would have the best chance of succeeding and saving lives. |
|
|
|
|
|
|
|
|
|
In addition to Vradenburg, Dychtwald, Genova and Edgcumbe, a world-class team of scientists, advisors and advocates have joined forces to propel this XPRIZE initiative, including: Maria Shriver, activist, journalist, former first lady of California; Geoffrey Ling, MD, PhD, former Founding Director of bio-tech at DARPA; Rudi Tanzi, PhD, Professor of Neurology, Harvard University; Reisa Sperling, MD, Professor of Neurology, Harvard Medical School; Ajay Verma, MD, PhD, CMO, at United Neurosciences; Daniel Kraft, MD, Founding Executive Director Exponential Medicine, Singularity University; and Cori Lathan, PhD, Founder and Chief Executive Officer of AnthroTronix. |
|
|
|
|
|
|
|
About
XPRIZE:
|
|
|
|
|
XPRIZE, a 501(c)(3) nonprofit, is the global leader in designing and implementing innovative competition models to solve the world’s grandest challenges. XPRIZE utilizes a unique combination of gamification, crowdsourcing, incentive prize theory, and exponential technologies as a formula to make 10x (vs. 10%) impact in the grand challenge domains facing our world. XPRIZE’s philosophy is that—under the right circumstances— igniting rapid experimentation from a variety of diverse lenses is the most efficient and effective method to driving exponential impact and solutions to grand challenges. Active competitions include the Google Lunar XPRIZE, the Global Learning XPRIZE, the Shell Ocean Discovery XPRIZE and the IBM Watson AI XPRIZE, http://www.xprize.org/.
|
|
|
|
|
|
|
View source version on businesswire.com: http://www.businesswire.com/news/home/20170906005483/en/
Contacts
UsAgainstAlzheimer’s
Jeannette O’Connor, 202-302-3268
Joconnor@usagainstalzheimers.org< /a>
or
Age Wave
Robyn Reynolds, 510-899-4004
rreynolds@agewave.com
|
